Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome.
Raijmakers, Ruud P H, Roerink, Megan E, Jansen, Anne F M et al. · Journal of translational medicine · 2020 · DOI
Quick Summary
This study compared people with Q fever fatigue syndrome (a prolonged tiredness that develops after a Q fever infection) to people with ME/CFS and healthy controls. Researchers examined three types of biological markers: gut bacteria, blood chemicals, and inflammatory proteins. They found that people with Q fever fatigue syndrome have very similar patterns to ME/CFS patients, suggesting these two conditions may share similar underlying biological mechanisms.
Why It Matters
This research suggests that Q fever fatigue syndrome and ME/CFS may share common biological pathways, which could help explain why both conditions cause similar prolonged fatigue symptoms. Identifying shared inflammatory markers (4E-BP1 and MMP-1) and metabolic changes provides potential biomarkers for diagnosis and could guide future treatment approaches for both conditions.
Observed Findings
Inflammatory markers 4E-BP1 and MMP-1 are significantly elevated in both QFS and CFS patients compared to healthy controls.
Both QFS and CFS patients show altered blood metabolite profiles with 319 and 441 differentially expressed metabolites respectively, enriched in sphingolipid metabolism pathways.
Gut microbiome composition differs in both QFS and CFS compared to controls, with reduced Bacteroides and Alistipes species and altered Ruminococcus and Bifidobacterium abundance.
When comparing QFS directly to CFS patients, almost no significant differences were found across metabolome or microbiome, suggesting remarkable biological similarity.
Inferred Conclusions
QFS and CFS patients show striking similarities across multiple biological systems (inflammatory, metabolic, and microbiome), suggesting shared pathogenic mechanisms.
4E-BP1 and MMP-1 may serve as potential biomarkers to distinguish both QFS and CFS patients from healthy individuals.
The similar molecular profiles between QFS and CFS support the hypothesis that post-infectious fatigue syndrome and ME/CFS may involve overlapping biological pathways.
Remaining Questions
Do the observed metabolic and inflammatory differences play a causal role in fatigue, or are they secondary consequences of the disease?
How do these biomarkers and molecular signatures change over time in individual patients, and do they correlate with symptom severity or recovery?
What This Study Does Not Prove
This study does not prove that Q fever causes ME/CFS or that the two conditions are identical—only that they share similar biological signatures. The cross-sectional design means we cannot determine whether these molecular changes cause fatigue or are consequences of it. The findings are correlational and do not establish mechanistic causation or therapeutic interventions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What are the specific mechanistic links between altered sphingolipid metabolism, elevated 4E-BP1/MMP-1, microbiome changes, and the fatigue symptom itself?
Can these identified markers predict which acute Q fever patients will develop QFS, or stratify patients for targeted interventions?